Tandem Diabetes Care, Inc.
U.S. healthcare company
TNDM Nasdaq
ISIN US8753722037 SEC CIK 1438133 LEI 549300JEPFOD0K4D3I05
Follow Tandem Diabetes Care
Weekly email: filings, results
Revenue, last quarter
$283.7M
+13.8% vs same quarter last year
Net income
−$7.1M
+66.5% vs same quarter last year
EPS, diluted
−$0.10
+67.7% vs same quarter last year
Operating cash flow
−$819K
−109.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1B | −$204.7M |
| FY24 | $940.2M | −$96M |
| FY23 | $747.7M | −$222.6M |
| FY22 | $801.2M | −$94.6M |
| FY21 | $702.8M | $15.6M |
| FY20 | $498.8M | −$34.4M |
| FY19 | $362.3M | −$24.8M |
| FY18 | $183.9M | −$122.6M |
| FY17 | $107.6M | −$73M |
| FY16 | $84.2M | −$83.4M |
| FY15 | $72.9M | −$72.4M |
| FY14 | $49.7M | −$79.5M |
| FY13 | $29M | −$63.1M |
| FY12 | $2.5M | −$33M |
| FY11 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 53.8% | −18.5% | −20.2% |
| FY24 | 52.1% | −10.5% | −10.2% |
| FY23 | 49.2% | −31.2% | −29.8% |
| FY22 | 51.5% | −11.6% | −11.8% |
| FY21 | 53.5% | 3.2% | 2.2% |
| FY20 | 52.2% | −1.6% | −6.9% |
| FY19 | 53.6% | −4.6% | −6.8% |
| FY18 | 48.9% | −24.3% | −66.7% |
| FY17 | 41% | −58.5% | −67.9% |
| FY16 | 28% | −92.6% | −99% |
| FY15 | 36.5% | −94.7% | −99.4% |
| FY14 | 30.7% | −152.2% | −159.9% |
| FY13 | 21.3% | −170.4% | −217.7% |
| FY12 | −54.5% | −1335.3% | −1333.9% |
| FY11 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$29.7M |
| FY24 | $5M |
| FY23 | −$58.6M |
| FY22 | $16.4M |
| FY21 | $97.2M |
| FY20 | −$2.7M |
| FY19 | $22.4M |
| FY18 | −$11.3M |
| FY17 | −$71.9M |
| FY16 | −$70.1M |
| FY15 | −$64.5M |
| FY14 | −$65.8M |
| FY13 | −$51.8M |
| FY12 | −$38M |
| FY11 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $0 |
| FY24 | $30M |
| FY23 | $0 |
| FY22 | $0 |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | - |
| FY12 | - |
| FY11 | - |
- Tandem Diabetes Care
- Healthcare median
Show the numbers
| Year | Tandem Diabetes Care | Healthcare median |
|---|---|---|
| FY25 | −20.2% | −30.6% |
| FY24 | −10.2% | −47% |
| FY23 | −29.8% | −58% |
| FY22 | −11.8% | −80.4% |
| FY21 | 2.2% | −71.8% |
| FY20 | −6.9% | −62.2% |
| FY19 | −6.8% | −46.2% |
| FY18 | −66.7% | −49.6% |
| FY17 | −67.9% | −45.9% |
| FY16 | −99% | −36% |
| FY15 | −99.4% | −37.8% |
| FY14 | −159.9% | −35.5% |
| FY13 | −217.7% | −37.1% |
| FY12 | −1333.9% | −29.1% |
| FY11 | - | −27.9% |